An important mission for science today is to develop better diagnostics and better treatments of severe diseases
such as amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD). Recently, a research group at Umeå
University, Sweden, has shed new light on the possibility to improve the diagnosis of ALS and PD and better
understand the disease progression.